Antibody Panels and Kits

Combinations of antibody-related products that may include sets of antibodies in pairs and cocktails, control particles, buffers, and other kits and panels; for use in specific applications such as immunoassays and T-cell activation.

391 – 405 of 922 results

391

PERKINELMER HEALTH SCIENCES INC LANCE EMULTRAEM HUMAN ANGPTL-4

50-281-4488 LANCE EMULTRAEM HUMAN ANGPTL-4

Pricing & Availability

392

PERKINELMER HEALTH SCIENCES INC DELFIA EU-LABELED RABBIT ANTI-

50-281-4663 DELFIA EU-LABELED RABBIT ANTI-

Pricing & Availability

393

PERKINELMER HEALTH SCIENCES INC DELFIA EU-LABELED RABBIT ANTI-

50-281-4691 DELFIA EU-LABELED RABBIT ANTI-

Pricing & Availability

394

PERKINELMER HEALTH SCIENCES INC LANCE EMULTRAEM HUMAN ANGPTL-4

50-281-4675 LANCE EMULTRAEM HUMAN ANGPTL-4

Pricing & Availability

395

PERKINELMER HEALTH SCIENCES INC DELFIA EU-LABELED RABBIT ANTI-

50-281-4740 DELFIA EU-LABELED RABBIT ANTI-

Pricing & Availability

396

PBL Assay Science Human Type I Interferon (IFN) Neutralizing Antibody Mixture (NAb) [0.2 mL]

Human Type I Interferon Neutralizing Antibody Mixture is manufactured by PBL Assay Science (Catalog #39000-1) for research use only (RUO) and packaged in 0.2 ml vials. This is a mixture of antibodies directed against human Type I interferon receptor (IFNAR2) and several Type I IFNs. This product effectively neutralizes biological activity of human IFN alpha, beta, omega, kappa, and epsilon.

Pricing & Availability

397

BD BIOSCIENCES 3P CD4/CD69/CD3

50-620-111 CD4/CD69/CD3

Pricing & Availability

398

Revvity Health Sciences Inc HTRF KinEASE STK S1 Kit, 1,000 Assay Points

HTRF KinEASE STK S1 Kit, 1,000 Assay Points

Pricing & Availability

399

Biocare Medical, LLC D2-40 (Lymphatic Marker) Antibody - Concentrate, 1.0 ml

D2-40 antibody is a selective marker of lymphatic endothelium in normal tissues and vascular lesions. Studies have shown [D2-40] staining in lymphatic channel endothelium, but not in the adjacent capillary. In the same study, D2-40 stained endothelium of lymphangiomas; whereas hemangiomas, glomus tumors, angiolipomas, pyogenic granulomas and vascular malformations were negative for staining. D2-40 has also been shown to react with Kaposi sarcoma and a subset of angiosarcomas. Studies indicate that D2-40 may be a very specific marker for malignant mesothelioma.